We are live on ! Find out more

316 hedge funds and large institutions have $5.58B invested in DexCom in 2016 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 113 increasing their positions, 91 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

442.4% more ownership

Funds ownership: 0%442.4% (+442%)

61% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 49

24% more repeat investments, than reductions

Existing positions increased: 113 | Existing positions reduced: 91

9% more funds holding

Funds holding: 291316 (+25)

29% less capital invested

Capital invested by funds: $7.84B → $5.58B (-$2.26B)

57% less funds holding in top 10

Funds holding in top 10: 73 (-4)

92% less call options, than puts

Call options by funds: $30.6M | Put options by funds: $396M

Holders
316
Holders Change
+25
Holders Change %
+8.59%
% of All Funds
7.88%
Holding in Top 10
3
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-57.14%
% of All Funds
0.07%
New
79
Increased
113
Reduced
91
Closed
49
Calls
$30.6M
Puts
$396M
Net Calls
-$365M
Net Calls Change
+$191M

DXCM Hedge Fund Activity: Q4 2016 in Review

316 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2016, worth a combined $5.58B — down 29% from $7.84B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new DXCM positions and 49 closed out — a net gain of 30 holders — while 113 added to existing stakes and 91 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $126M. The largest seller was Federated Hermes, cutting an estimated $170M.

  • 316 institutional investors held DexCom (DXCM) as of Q4 2016, up from 291 in Q3 2016.
  • Funds reported $5.58B of DexCom stock for Q4 2016, down 29% quarter-over-quarter.
  • 79 funds opened new DexCom positions in Q4 2016 and 49 closed out, a net change of +30 holders.
  • The largest DexCom buyer in Q4 2016 was Janus Henderson Investors US, an estimated $126M added.
  • The largest DexCom seller in Q4 2016 was Federated Hermes, an estimated $170M sold.

Based on aggregated 13F filings for Q4 2016.